Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.
<h4>Background</h4>Clinical studies demonstrate that the N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, induces rapid antidepressant effects in patients with refractive major depressive disorder and bipolar depression. This rapid onset of action makes ketamine a highly attrac...
Main Authors: | Xian-Cang Ma, Yong-Hui Dang, Min Jia, Rui Ma, Fen Wang, Jin Wu, Cheng-Ge Gao, Kenji Hashimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23390559/pdf/?tool=EBI |
Similar Items
-
Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
by: Jing Zhang, et al.
Published: (2021-01-01) -
Glycogen synthase kinase 3 (GSK3) inhibitor, SB-216763, promotes pluripotency in mouse embryonic stem cells.
by: Leslie A Kirby, et al.
Published: (2012-01-01) -
Corrigendum: Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
Published: (2021-01-01) -
SB216763, a selective small molecule inhibitor of glycogen synthase kinase-3, improves bleomycin-induced pulmonary fibrosis via activating autophagy
by: Hong Liu, et al.
Published: (2013-07-01) -
Small-Molecule SB216763-Loaded Microspheres Repair Peripheral Nerve Injury in Small Gap Tubulization
by: Feng Rao, et al.
Published: (2019-05-01)